Objective: This study aims to evaluate the safety and gastrointestinal tolerance of MaxvidaTM high protein in hospitalized adult patients requiring an isocaloric high protein formula for enteral tube feeding.
Materials and methods: This was a prospective, twelve-day, single-centre, open-label clinical study, where the safety and gastrointestinal tolerance of MaxvidaTM high protein (30 grams in 100 millilitres of water) were evaluated every day from Day 1 to the end of hospitalization or Day 12. The reconstituted amount was 116 ml (equivalent to 114 kcal {1 kcal in 1 ml}) and administered twice a day along with isocaloric kitchen feed (1 kcal in 1 ml) as per the patient’s requirement or at the discretion of the investigator.
Results: All the participants received the feed twice a day during the study period. Two participants experienced vomiting during the study period. Gastric Residual Volume did not exceed 500 ml/day for any subjects. There was no safety issue encountered during the administration of MaxvidaTM high protein.
Conclusion: MaxvidaTM high protein was found to be a safe and well-tolerated enteral tube nutrition formula for hospitalized adults.
Select your language of interest to view the total content in your interested language
Annals of Medical and Health Sciences Research received 24805 citations as per google scholar report
The Annals of Medical and Health Sciences Research is a monthly multidisciplinary medical journal.